Listen: Democratizing CRISPR, drugging the undruggable, and reading pharma’s fine print
In the latest episode of our #biotech #podcast, "The Readout LOUD," we cover a fascinating #CRISPR debate and one company's efforts to craft pills that can do what has thus…
Who gets to “play God”? Can old technologies learn new tricks? And what does “drug price” even mean?
We discuss all
